Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IPHC 2027

Diabetes at IPHC 2027

Part of the IPHC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Diabetes Session

Diabetes, usually referred to as diabetes mellitus, is a collection of metabolic illnesses characterised by persistently elevated blood sugar levels (hyperglycemia). Frequent urination, increased thirst, and increased hunger are common symptoms. Diabetes can lead to a wide range of health issues if neglected. Hyperosmolar hyperglycemia, diabetic ketoacidosis, and even mortality are examples of acute complications. Cardiovascular disease, stroke, chronic renal disease, foot ulcers, eye damage, nerve damage, and cognitive impairment are examples of serious long-term consequences. Diabetes results from either insufficient insulin production by the pancreas or improper insulin use by the body's cells. A hormone called insulin is in charge of facilitating the entry of food-derived glucose into cells for cellular energy use. The three primary kinds of diabetes mellitus are as follows:

Type 1 diabetes is brought on by the pancreas' inability to generate enough insulin as a result of beta cell loss. Previously, this kind was referred to as "juvenile diabetes" or "insulin-dependent diabetes mellitus." Beta cell loss is brought on by an autoimmune reaction. This autoimmune reaction's origin is uncertain. While Type 1 diabetes often first manifests in infancy or adolescence, it can also strike adults.

Type 2 diabetes is an Insulin resistance, a disease in which cells do not react to insulin as it should, is the precursor to type 2 diabetes.A shortage of insulin may also occur as the condition worsens. Previously, this kind was referred to as "adult-onset diabetes" or "non-insulin-dependent diabetes mellitus."
Gestational Diabetes is the third major kind of diabetes, known as gestational diabetes, affects pregnant women who have never had the disease. After delivery, blood sugar levels in women with gestational diabetes often recover to normal. The chance of acquiring type 2 diabetes later in life is increased for women who had gestational diabetes during pregnancy.

Topics Covered in Diabetes

Topic 01

Type 1 diabetes and autoimmune beta cell loss

Topic 02

Type 2 diabetes and insulin resistance

Topic 03

Gestational diabetes and pregnancy outcomes

Topic 04

Acute hyperglycemic crises and ketoacidosis

Topic 05

Diabetic complications of eye, kidney and nerve

Topic 06

Glycemic control, screening and self-management

Featured Speakers — Diabetes 2027

Browse all speakers →

Recent Research Presented at Diabetes Sessions

Related Scientific Sessions at IPHC 2027

Why Attend the Diabetes Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Diabetes work, reviewed by the scientific committee.

Network Globally

Meet public health researchers, educators, and policy leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Diabetes research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IPHC 2027 for the Diabetes track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Diabetes Conference 2027 — FAQs

What is the Diabetes track at IPHC 2027?

The Diabetes track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Diabetes. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Diabetes sessions?

Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Diabetes are all welcome — whether presenting or attending.

Can I present my research in the Diabetes track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Diabetes sessions?

Yes. IPHC 2027 is a hybrid conference — attend the Diabetes track in person in Singapore or join live online, with on-demand access afterward.

Join the IPHC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us